World's Best Scientists 2026 revealed!
Dominique Figarella-Branger

Dominique Figarella-Branger

D-Index & Metrics

Medicine

D-Index
105
Citations
64607
World Ranking
6652
National Ranking
197

Overview

Dominique Figarella-Branger is affiliated with Aix-Marseille University in France and has made significant contributions to the fields of medicine and biochemistry, genetics, and molecular biology. Their research primarily focuses on glioma diagnosis and treatment, meningioma and schwannoma management, and brain metastases and treatment. Additional areas of study include neuroblastoma research and treatments, cancer genomics and diagnostics, pituitary gland disorders and treatments, and chromatin remodeling and cancer.

Their publication record shows a strong presence in neuropathology and neuro-oncology, having frequently published in the following venues:

  • Neuro-Oncology
  • Neuro-Oncology Advances
  • Neuropathology and Applied Neurobiology
  • Journal of Neuro-Oncology
  • bioRxiv (Cold Spring Harbor Laboratory)

Dominique has collaborated extensively with several researchers, including:

  • Émeline Tabouret
  • François Ducray
  • Olivier Chinot
  • Romain Appay
  • Caroline Dehais

Their work is well represented by a selection of recent papers, as follows:

  • The 2021 WHO Classification of Tumors of the Central Nervous System: a summary (2021, Neuro-Oncology)
  • cIMPACT-NOW update 6: new entity and diagnostic principle recommendations of the cIMPACT-Utrecht meeting on future CNS tumor classification and grading (2020, Brain Pathology)
  • Challenges in glioblastoma research: focus on the tumor microenvironment (2022, Trends in cancer)
  • Everolimus and Octreotide for Patients with Recurrent Meningioma: Results from the Phase II CEVOREM Trial (2020, Clinical Cancer Research)
  • Molecular diagnostic tools for the World Health Organization (WHO) 2021 classification of gliomas, glioneuronal and neuronal tumors; an EANO guideline (2023, Neuro-Oncology)

Their expertise covers a wide range of topics within neuroscience and oncology, including:

  • Glioma diagnosis and treatment
  • Meningioma and schwannoma management
  • Brain metastases and treatment
  • Neuroblastoma research and treatments
  • Cancer genomics and diagnostics
  • Pituitary gland disorders and treatments
  • Chromatin remodeling and cancer

Dominique Figarella-Branger's work spans a substantial number of publications, with around 190 works classified under medicine and 58 under biochemistry, genetics, and molecular biology. They have published notably on subfields including genetics, molecular biology, pulmonary and respiratory medicine, neurology, and epidemiology.

Best Publications

  • The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary.

    David N. Louis;Arie Perry;Guido Reifenberger;Andreas von Deimling

  • The 2021 WHO Classification of Tumors of the Central Nervous System: a summary.

    David N Louis;Arie Perry;Pieter Wesseling;Daniel J Brat

  • New Brain Tumor Entities Emerge from Molecular Classification of CNS-PNETs

    Dominik Sturm;Dominik Sturm;Brent A. Orr;Umut H. Toprak;Volker Hovestadt

  • International Society of Neuropathology-Haarlem Consensus Guidelines for Nervous System Tumor Classification and Grading

    David N. Louis;Arie Perry;Peter Burger;David W. Ellison

  • OPA1 mutations induce mitochondrial DNA instability and optic atrophy plus phenotypes

    Patrizia Amati-Bonneau;Maria Lucia Valentino;Pascal Reynier;Maria Esther Gallardo

  • A new prognostic clinicopathological classification of pituitary adenomas: a multicentric case–control study of 410 patients with 8 years post-operative follow-up

    Jacqueline Trouillas;Jacqueline Trouillas;Pascal Roy;Nathalie Sturm;Emmanuelle Dantony

  • cIMPACT-NOW update 6: new entity and diagnostic principle recommendations of the cIMPACT-Utrecht meeting on future CNS tumor classification and grading.

    David N. Louis;Pieter Wesseling;Kenneth Aldape;Daniel J. Brat

  • Central neurocytoma: a synopsis of clinical and histological features.

    Jacques Hassoun;Figen Söylemezoglu;Danielle Gambarelli;Dominique Figarella‐Branger

  • cIMPACT-NOW update 2: diagnostic clarifications for diffuse midline glioma, H3 K27M-mutant and diffuse astrocytoma/anaplastic astrocytoma, IDH-mutant

    David N. Louis;Caterina Giannini;David Capper;Werner Paulus

  • Hyperfractionated Versus Conventional Radiotherapy Followed by Chemotherapy in Standard-Risk Medulloblastoma: Results From the Randomized Multicenter HIT-SIOP PNET 4 Trial

    Birgitta Lannering;Stefan Rutkowski;Francois Doz;Barry Pizer

  • Survival and Prognostic Factors of Early Childhood Medulloblastoma: An International Meta-Analysis

    Stefan Rutkowski;Katja Von Hoff;Angela Emser;Isabella Zwiener

  • Pilocytic astrocytomas in children: prognostic factors--a retrospective study of 80 cases.

    Carla Fernandez;Dominique Figarella-Branger;Nadine Girard;Corinne Bouvier-Labit

  • Absence of IDH mutation identifies a novel radiologic and molecular subtype of WHO grade II gliomas with dismal prognosis.

    Philippe Metellus;Bema Coulibaly;Carole Colin;Carole Colin;Andre Maues de Paula

  • Macrophagic myofasciitis: an emerging entity

    R K Gherardi;M Coquet;P Chérin;F J Authier

  • SCENITH: A Flow Cytometry-Based Method to Functionally Profile Energy Metabolism with Single-Cell Resolution.

    Rafael J. Argüello;Alexis J. Combes;Remy Char;Julien-Paul Gigan

  • Histopathological grading of pediatric ependymoma: Reproducibility and clinical relevance in European trial cohorts

    David W Ellison;Mehmet Kocak;Dominique Figarella-Branger;Giangaspero Felice

  • Stereoelectroencephalography in presurgical assessment of MRI-negative epilepsy

    Aileen McGonigal;Fabrice Bartolomei;Jean Régis;Maxime Guye

  • Phenotypic Study in 40 Patients With Dysferlin Gene Mutations: High Frequency of Atypical Phenotypes

    Karine Nguyen;Guillaume Bassez;Martin Krahn;Rafaelle Bernard

  • Recurrent Mutations of MYD88 and TBL1XR1 in Primary Central Nervous System Lymphomas

    Alberto Gonzalez-Aguilar;Ahmed Idbaih;Blandine Boisselier;Naima Habbita

  • Pituitary tumors and hyperplasia in multiple endocrine neoplasia type 1 syndrome (MEN1): a case-control study in a series of 77 patients versus 2509 non-MEN1 patients.

    Jacqueline Trouillas;Françoise Labat-Moleur;Nathalie Sturm;Michèle Kujas

Frequent Co-Authors

Ahmed Idbaih
Ahmed Idbaih Sorbonne University
Thierry Brue
Thierry Brue Aix-Marseille University
Pieter Wesseling
Pieter Wesseling University of Amsterdam
Torsten Pietsch
Torsten Pietsch University of Bonn
Stefan M. Pfister
Stefan M. Pfister German Cancer Research Center
Marc Sanson
Marc Sanson Sorbonne University
Felice Giangaspero
Felice Giangaspero Sapienza University of Rome
Geneviève Rougon
Geneviève Rougon Centre national de la recherche scientifique, CNRS
François Doz
François Doz Université Paris Cité
Andreas von Deimling
Andreas von Deimling Heidelberg University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For students inspired by Medicine but seeking alternative or complementary paths, online nursing and healthcare degrees offer flexible opportunities. Many colleges now provide accredited remote programs—letting you upskill without leaving your current job or home community.

One popular option is pursuing one of the cheapest bsn programs online, which preps you for entry-level nursing roles at a lower cost. If you’re already a registered nurse, rn to bsn online programs make it possible to advance your education and boost your career prospects quickly and affordably.

Some professionals are looking for advanced leadership tracks, and the cheapest online dnp programs deliver a doctoral-level credential for experienced nurses. If your bachelor’s is outside nursing, non nursing bachelor's to msn online programs provide a fast route into the profession without starting from scratch.

These online degree pathways open doors in healthcare, meeting the growing demand for qualified professionals while providing affordable, accessible learning options for all backgrounds.

Best Scientists Citing Dominique Figarella-Branger

Trending Scientists